$WNLV
Winvest Group Ltd

2024 Q4 Form 10-Q Financial Statement

#000147793224007402 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $0.00 $50.00K
YoY Change -100.0% 1049.43%
Cost Of Revenue
YoY Change
Gross Profit $35.00K
YoY Change 803.69%
Gross Profit Margin 70.0%
Selling, General & Admin $94.77K
YoY Change 41.34%
% of Gross Profit 270.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $153.1K $94.77K
YoY Change 61.59% -37.35%
Operating Profit -$153.1K -$59.77K
YoY Change 156.21% -59.45%
Interest Expense $788.00 $3.368K
YoY Change -76.6% 455.78%
% of Operating Profit
Other Income/Expense, Net -$12.00 -$3.368K
YoY Change -99.64% 455.78%
Pretax Income -$39.33K -$63.14K
YoY Change -37.71% -57.34%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$39.33K -$63.14K
YoY Change -37.71% -57.34%
Net Earnings / Revenue -126.28%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 109.4M shares 85.16M 17.53M shares
Diluted Shares Outstanding 18.33M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.81K
YoY Change 224.52%
Cash & Equivalents $289.0K $43.81K
Short-Term Investments
Other Short-Term Assets $62.18K
YoY Change 2255.3%
Inventory
Prepaid Expenses $155.6K $62.18K
Receivables $19.20K $4.100K
Other Receivables $0.00
Total Short-Term Assets $468.8K $124.4K
YoY Change 276.84% 670.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.890K
YoY Change
Other Assets $1.090K
YoY Change
Total Long-Term Assets $11.98K $1.894K
YoY Change 532.37% -99.9%
TOTAL ASSETS
Total Short-Term Assets $468.8K $124.4K
Total Long-Term Assets $11.98K $1.894K
Total Assets $480.8K $126.3K
YoY Change 280.67% -93.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.378K $38.03K
YoY Change -93.75% 91.74%
Accrued Expenses $64.15K $15.94K
YoY Change 302.49% 29.0%
Deferred Revenue
YoY Change
Short-Term Debt $793.6K
YoY Change 88.39%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.276M $987.6K
YoY Change 29.24% 117.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.276M $987.6K
Total Long-Term Liabilities $0.00
Total Liabilities $1.276M $987.6K
YoY Change 29.24% 117.81%
SHAREHOLDERS EQUITY
Retained Earnings -$104.8M -$104.7M
YoY Change 0.14% 2.74%
Common Stock $285.2K $18.33K
YoY Change 1456.04% 5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$795.6K -$861.3K
YoY Change
Total Liabilities & Shareholders Equity $480.8K $126.3K
YoY Change 280.67% -93.44%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$39.33K -$63.14K
YoY Change -37.71% -57.34%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities -$92.76K
YoY Change 50.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.38K
YoY Change -62.27%
NET CHANGE
Cash From Operating Activities -92.76K
Cash From Investing Activities 0.000
Cash From Financing Activities 23.38K
Net Change In Cash -69.38K
YoY Change 391.01%
FREE CASH FLOW
Cash From Operating Activities -$92.76K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1810116 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
289039 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
45070 usd
CY2023Q4 wnlv Project Advances
ProjectAdvances
250000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
0 usd
CY2023Q3 wnlv Conversion Of Stock Shares Additional Limit
ConversionOfStockSharesAdditionalLimit
9200000 shares
wnlv Proceeds From Sale Of Investment Shares
ProceedsFromSaleOfInvestmentShares
389566 shares
wnlv Proceeds From Sale Of Investment
ProceedsFromSaleOfInvestment
263967 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
263578 usd
CY2024Q3 us-gaap Investments
Investments
9611 usd
CY2023Q4 us-gaap Investments
Investments
800 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
18670 usd
CY2024Q3 wnlv Notes Payable Related Parties
NotesPayableRelatedParties
659860 usd
CY2023Q4 wnlv Notes Payable Related Parties
NotesPayableRelatedParties
631157 usd
CY2023 wnlv Additions Of Related Parties
AdditionsOfRelatedParties
29508 usd
wnlv Repayments To Related Parties
RepaymentsToRelatedParties
0 usd
CY2023 wnlv Repayments To Related Parties
RepaymentsToRelatedParties
0 usd
CY2024Q3 wnlv Project Advances
ProjectAdvances
550000 usd
CY2023Q4 wnlv Project Advances
ProjectAdvances
250000 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28074 usd
CY2023Q3 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
161923 usd
CY2024Q3 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
28074 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
161923 usd
CY2024Q3 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
0 usd
CY2024Q3 wnlv Net Changes In Deferred Income Tax Benefit
NetChangesInDeferredIncomeTaxBenefit
0 usd
CY2023Q3 wnlv Net Changes In Deferred Income Tax Benefit
NetChangesInDeferredIncomeTaxBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
wnlv Net Loss Before Income Tax
NetLossBeforeIncomeTax
-101727 usd
wnlv Net Loss Before Income Tax
NetLossBeforeIncomeTax
-771064 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
161923 usd
CY2024Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
28074 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
161923 usd
CY2024Q3 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
28074 usd
CY2023Q3 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
161923 usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
64149 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Share Based Compensation
ShareBasedCompensation
458040 usd
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
855000 shares
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Each share of preferred stock is convertible to 50 shares of common stock.
dei Entity Central Index Key
EntityCentralIndexKey
0001558740
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
285159075 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56204
dei Entity Registrant Name
EntityRegistrantName
WINVEST GROUP LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2052033
dei Entity Address Address Line1
EntityAddressAddressLine1
50 West Liberty Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 880
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89501
dei City Area Code
CityAreaCode
775
dei Local Phone Number
LocalPhoneNumber
996-0288
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
109369075 shares
CY2024Q3 us-gaap Cash
Cash
289039 usd
CY2023Q4 us-gaap Cash
Cash
45070 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19200 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4100 usd
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4948 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
15710 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
155605 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
61230 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
468792 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
126110 usd
CY2024Q3 us-gaap Investments
Investments
9611 usd
CY2023Q4 us-gaap Investments
Investments
800 usd
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
2366 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
1094 usd
CY2024Q3 us-gaap Assets
Assets
480769 usd
CY2023Q4 us-gaap Assets
Assets
128004 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2378 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
76451 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64149 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54317 usd
CY2024Q3 wnlv Project Advances Current
ProjectAdvancesCurrent
400000 usd
CY2023Q4 wnlv Project Advances Current
ProjectAdvancesCurrent
100000 usd
CY2024Q3 wnlv Project Advances Related Party Current
ProjectAdvancesRelatedPartyCurrent
150000 usd
CY2023Q4 wnlv Project Advances Related Party Current
ProjectAdvancesRelatedPartyCurrent
150000 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
18670 usd
CY2024Q3 wnlv Notes Payablerelated Parties Current
NotesPayablerelatedPartiesCurrent
659860 usd
CY2023Q4 wnlv Notes Payablerelated Parties Current
NotesPayablerelatedPartiesCurrent
631157 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1276387 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1030595 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1276387 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1030595 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
222689 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
227839 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
285159075 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18326075 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
285159 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
18326 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103518814 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103571797 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104822280 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104720553 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-795618 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-902591 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
480769 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128004 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
50000 usd
us-gaap Revenues
Revenues
77340 usd
us-gaap Revenues
Revenues
214978 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
15000 usd
us-gaap Cost Of Revenue
CostOfRevenue
42760 usd
us-gaap Cost Of Revenue
CostOfRevenue
123307 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
35000 usd
us-gaap Gross Profit
GrossProfit
34580 usd
us-gaap Gross Profit
GrossProfit
91671 usd
CY2024Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
153137 usd
CY2023Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
94771 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
398894 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
930720 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
153137 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
94771 usd
us-gaap Operating Expenses
OperatingExpenses
398894 usd
us-gaap Operating Expenses
OperatingExpenses
930720 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-153137 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-59771 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-364314 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-839049 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
788 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
3368 usd
us-gaap Interest Expense
InterestExpense
2832 usd
us-gaap Interest Expense
InterestExpense
9467 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1841 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
114606 usd
CY2023Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
263578 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
14313 usd
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
113806 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3368 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
262587 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
4846 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39331 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63139 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101727 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-834203 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-39331 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-63139 usd
us-gaap Net Income Loss
NetIncomeLoss
-101727 usd
us-gaap Net Income Loss
NetIncomeLoss
-834203 usd
CY2024Q3 wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
CY2023Q3 wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
wnlv Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.05
CY2024Q3 wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
248202553 shares
CY2023Q3 wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
18326075 shares
wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
335648035 shares
wnlv Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
17501327 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-485968 usd
CY2023Q1 wnlv Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
458040 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-654791 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-682719 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-116273 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-798992 usd
CY2023Q3 wnlv Common Shares Issued As Investment Amount
CommonSharesIssuedAsInvestmentAmount
800 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-63139 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-861330 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-902591 usd
CY2024Q1 wnlv Issuance Of Shares For Investment Amount
IssuanceOfSharesForInvestmentAmount
9200 usd
CY2024Q1 wnlv Conversion Of Preferred Stock To Common Stock Amount
ConversionOfPreferredStockToCommonStockAmount
0 usd
CY2024Q1 wnlv Private Placement Of Common Amount
PrivatePlacementOfCommonAmount
199500 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8656 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-702547 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-53740 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-756287 usd
CY2024Q3 wnlv Conversion Of Preferred Stock To Common Stock Amount
ConversionOfPreferredStockToCommonStockAmount
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-39331 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-795618 usd
us-gaap Profit Loss
ProfitLoss
101727 usd
us-gaap Profit Loss
ProfitLoss
834203 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
458040 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
263578 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15100 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24047 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-10762 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
14310 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
94375 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-93172 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-1272 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1094 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-74073 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14284 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
309832 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5101 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40071 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-229531 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-225094 usd
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
263967 usd
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
263967 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
0 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
41937 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
18670 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
199500 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
9000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
113736 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
37703 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
303556 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
209533 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231757 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
243969 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6663 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45070 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37148 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
289039 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43811 usd
wnlv Purchase Of Investment With Common Shares
PurchaseOfInvestmentWithCommonShares
9200 usd
wnlv Purchase Of Investment With Common Shares
PurchaseOfInvestmentWithCommonShares
0 usd
CY2012Q1 wnlv Issuance Of Common Stock For Donated Service
IssuanceOfCommonStockForDonatedService
98984744 shares
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 250
CY2024Q3 wnlv Working Capital Deficit
WorkingCapitalDeficit
-807595 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104822280 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities at the date of the condensed consolidated financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these condensed financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>
us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The cost of revenue is comprised of labor expenses calculated based on an hourly labor rate provided by consultants and employees to produce revenue, as well as portion of office expense which is allocated to each project. Additionally, the cost of revenue includes direct expenses related to the revenues provided, such as managing the client’s Amazon sales channel through the creation of promotional advertisements to increase sales, translation of content into different languages, coordination of projects with different work teams to maximize client benefits, production crew for celebrity endorsements and video shooting, and salaries and wages of employees involved in creating and delivering these services.</p>
CY2024Q3 wnlv Project Advances
ProjectAdvances
550000 usd
CY2024Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
0 usd
CY2023Q3 wnlv Debt Conversion Converted Instrument Shares Agreement Grants
DebtConversionConvertedInstrumentSharesAgreementGrants
(i) the right to repurchase its Series A Preferred stock from the Company at a purchase price to be determined by IFA’s valuation at the time of repurchase; and (ii) anti-dilution protection in the event the Company issues any shares of its Common stock below $1.50 per share
wnlv Advances From Related Parties Beginning Period
AdvancesFromRelatedPartiesBeginningPeriod
633933 usd
CY2023 wnlv Advances From Related Parties Beginning Period
AdvancesFromRelatedPartiesBeginningPeriod
601649 usd
wnlv Additions Of Related Parties
AdditionsOfRelatedParties
25927 usd
wnlv Advances From Related Parties Ending Period
AdvancesFromRelatedPartiesEndingPeriod
659860 usd
CY2023 wnlv Advances From Related Parties Ending Period
AdvancesFromRelatedPartiesEndingPeriod
631157 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
104822280 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
wnlv Tax Expenses Benefit At The Statutory Tax Rate Net
TaxExpensesBenefitAtTheStatutoryTaxRateNet
-21363 usd
wnlv Tax Expenses Benefit At The Statutory Tax Rate Net
TaxExpensesBenefitAtTheStatutoryTaxRateNet
-161923 usd
wnlv Loss Brought Forward
LossBroughtForward
-6711 usd
wnlv Loss Brought Forward
LossBroughtForward
0 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28074 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
285159075 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18326075 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3420 shares

Files In Submission

Name View Source Status
0001477932-24-007402-index-headers.html Edgar Link pending
0001477932-24-007402-index.html Edgar Link pending
0001477932-24-007402.txt Edgar Link pending
0001477932-24-007402-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wnlv-20240930.xsd Edgar Link pending
wnlv_10q.htm Edgar Link pending
wnlv_ex311.htm Edgar Link pending
wnlv_ex312.htm Edgar Link pending
wnlv_10q_htm.xml Edgar Link completed
wnlv_ex321.htm Edgar Link pending
wnlv_ex322.htm Edgar Link pending
wnlv-20240930_cal.xml Edgar Link unprocessable
wnlv-20240930_def.xml Edgar Link unprocessable
wnlv-20240930_lab.xml Edgar Link unprocessable
wnlv-20240930_pre.xml Edgar Link unprocessable